0001708138-20-000038.txt : 20200416
0001708138-20-000038.hdr.sgml : 20200416
20200416160427
ACCESSION NUMBER: 0001708138-20-000038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200414
FILED AS OF DATE: 20200416
DATE AS OF CHANGE: 20200416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAROSA JOSEPH J
CENTRAL INDEX KEY: 0001238303
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20796396
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-04-14
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001238303
LAROSA JOSEPH J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP General Counsel and Secret
Common Stock
2020-04-14
4
M
0
5000
59.2
A
19438
D
Common Stock
2020-04-14
4
F
0
2738
521.45
D
16700
D
Common Stock
2020-04-15
4
S
0
92
514.63
D
16608
D
Common Stock
2020-04-15
4
S
0
414
515.7
D
16194
D
Common Stock
2020-04-15
4
S
0
260
516.81
D
15934
D
Common Stock
2020-04-15
4
S
0
266
517.4
D
15668
D
Common Stock
2020-04-15
4
S
0
499
518.25
D
15169
D
Common Stock
2020-04-15
4
S
0
286
519.43
D
14883
D
Common Stock
2020-04-15
4
S
0
220
520.45
D
14663
D
Common Stock
2020-04-15
4
S
0
113
521.05
D
14550
D
Common Stock
2020-04-15
4
S
0
106
524.99
D
14444
D
Common Stock
2020-04-15
4
S
0
6
525.3
D
14438
D
Common Stock
287
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
59.2
2020-04-14
4
M
0
5000
0.0
D
2021-09-01
Common Stock
5000
34933
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 414 shares of Company stock on April 15, 2020 at prices ranging from $515.30 to $515.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
Represents volume-weighted average price of sales of 260 shares of Company stock on April 15, 2020 at prices ranging from $516.06 to $516.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
Represents volume-weighted average price of sales of 266 shares of Company stock on April 15, 2020 at prices ranging from $517.00 to $517.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
Represents volume-weighted average price of sales of 499 shares of Company stock on April 15, 2020 at prices ranging from $518.03 to $518.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
Represents volume-weighted average price of sales of 286 shares of Company stock on April 15, 2020 at prices ranging from $519.25 to $519.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
Represents volume-weighted average price of sales of 220 shares of Company stock on April 15, 2020 at prices ranging from $520.29 to $520.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 15, 2020 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**Joseph J. LaRosa
2020-04-16